Related Experiment Video
Updated: May 17, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
IITZ01 attenuates fructose aggravated ulcerative colitis via prevention of macrophage activation and decrease in
Bishal Rajdev1, Snehashis Kundu1, Pallabi Panja1
1Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Guwahati, Assam 781101, India.
Abstract:
Excessive dietary fructose intake is gradually recognised to exacerbate intestinal inflammation in Ulcerative Colitis (UC) through disruption of epithelial barrier integrity and microbial dysbiosis, resulting in hyper immune activation. Inflammation in UC is generally linked with PI3K/Akt/mTOR pathway activation; however, the underlying molecular mechanisms behind fructose-mediated immune hyper-activation remains incompletely understood. Hence, this study is aimed to investigate the role of phosphatidylinositol-4-phosphate 5-kinases (PIP5Ks), a probable upstream regulator of PI3K, in high-fructose diet-induced colonic inflammation. In vitro and in vivo models of high fructose exposure were employed to evaluate the expression and functional role of PIP5Ks through pharmacological inhibition using ISA 2011B (PIP5K1A inhibitor) and IITZ01 (PIP5K1B inhibitor). Inflammatory responses, epithelial integrity, and disease severity were assessed using molecular, histological, and clinical indices in the high fructose + DSS induced UC in rodent model. High fructose exposure enhanced PIP5K expression, leading to increased levels of phosphatidylinositol 4,5-bisphosphate (PIP2), a key substrate for PI3K. This activation triggered downstream signalling that amplified inflammatory responses and compromised epithelial barrier function. Inhibition of PIP5Ks markedly attenuated fructose-induced inflammation in both cellular and animal models. Notably, IITZ01 demonstrated superior efficacy compared to ISA 2011B, as evidenced by improved disease activity index, restored epithelial structure, and reduced inflammatory burden. Collectively, our findings identify PIP5Ks as a critical mediator of fructose-induced intestinal inflammation and establish the PIP5K-PI3K signalling axis as a key regulator of macrophage activation and epithelial dysfunction. Targeting PIP5Ks may represent a promising therapeutic strategy for the management of UC.
More Related Videos
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Introduction